Table 1. Demographic characteristics.

			n	%
Characteristic (100 patients)	n	%	Pt treated with exemestane (50 patients)
Age (years)
Median	66
Range	30–93
Prior adjuvant treatment
Hormonal only	21	21
Cytotoxic only	25	25
Both	30	30
None	15	15
Unknown	9	9
Sites of metastatic disease
Bone	52	52	30	60
Skin	11	11	6	12
Lymph	16	16	9	18
Pleural effusion	6	6	5	10
Liver	19	19	15	30
Lung	14	14	10	20
Breast	17	17	10	20
Numbers of sites involved
1	64	64	23	46
2	26	26	15	30
3	8	8	10	20
>4	2	2	2	4
Performance Status
0	43	43	21	42
1	40	40	19	38
2	17	17	10	20
Receptor status
ER+, PgR+	66	67
ER+, PgR−	8	8
ER+, PgR unknown	0	0
ER−, PgR+	5	5
ER unknown, PgR+	0	0
Unknown	19	19